rs72646973

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The ENST00000329705.11(TBX1):​c.*11C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00199 in 1,614,062 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 2 hom. )

Consequence

TBX1
ENST00000329705.11 3_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -2.11

Publications

1 publications found
Variant links:
Genes affected
TBX1 (HGNC:11592): (T-box transcription factor 1) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
TBX1 Gene-Disease associations (from GenCC):
  • conotruncal heart malformations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • DiGeorge syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • velocardiofacial syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 22-19779418-C-T is Benign according to our data. Variant chr22-19779418-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 504975.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00121 (184/152230) while in subpopulation NFE AF = 0.00228 (155/68016). AF 95% confidence interval is 0.00199. There are 1 homozygotes in GnomAd4. There are 86 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 184 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBX1NM_080646.2 linkc.*11C>T 3_prime_UTR_variant Exon 9 of 9 NP_542377.1 O43435-1
TBX1NM_005992.1 linkc.1010-3495C>T intron_variant Intron 8 of 9 NP_005983.1 O43435-2Q152R5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBX1ENST00000329705.11 linkc.*11C>T 3_prime_UTR_variant Exon 9 of 9 1 ENSP00000331176.7 O43435-1
TBX1ENST00000359500.7 linkc.1010-3495C>T intron_variant Intron 8 of 9 1 ENSP00000352483.3 O43435-2

Frequencies

GnomAD3 genomes
AF:
0.00121
AC:
184
AN:
152112
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00228
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00131
AC:
330
AN:
251156
AF XY:
0.00132
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00116
Gnomad NFE exome
AF:
0.00233
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00207
AC:
3025
AN:
1461832
Hom.:
2
Cov.:
33
AF XY:
0.00197
AC XY:
1435
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.000568
AC:
19
AN:
33480
American (AMR)
AF:
0.000470
AC:
21
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86250
European-Finnish (FIN)
AF:
0.00112
AC:
60
AN:
53408
Middle Eastern (MID)
AF:
0.000695
AC:
4
AN:
5756
European-Non Finnish (NFE)
AF:
0.00252
AC:
2806
AN:
1111988
Other (OTH)
AF:
0.00166
AC:
100
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
151
301
452
602
753
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
98
196
294
392
490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00121
AC:
184
AN:
152230
Hom.:
1
Cov.:
33
AF XY:
0.00116
AC XY:
86
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41536
American (AMR)
AF:
0.000196
AC:
3
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10598
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00228
AC:
155
AN:
68016
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00214
Hom.:
1
Bravo
AF:
0.00127
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 27, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The c.*11C>T varian t in TBX1 has been reported in 1 individual with TOF and his presumably unaffect ed mother. The patient also carried variants in other genes associated with cong enital heart defects (Topf 2014). This variant has been identified in 0.2% (133/ 44688) of European chromosomes by the Exome Aggregation Consortium (ExAC, http:/ /exac.broadinstitute.org; dbSNP rs72646973). Although it has been seen in the ge neral population, its frequency is not high enough to rule out a pathogenic role . In summary, while the clinical significance of the c.*11C>T variant is uncerta in, its frequency suggest that it is more likely to be benign. -

not provided Benign:1
Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TBX1: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.77
DANN
Benign
0.64
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72646973; hg19: chr22-19766941; COSMIC: COSV61549749; COSMIC: COSV61549749; API